HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Douglas Bardini Silveira Selected Research

Interleukin-6 (Interleukin 6)

3/2022Pharmacological inhibition of UPR sensor PERK attenuates HIV Tat-induced inflammatory M1 phenotype in microglial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Douglas Bardini Silveira Research Topics

Disease

2Neurocognitive Disorders (Clerambault Syndrome)
11/2022 - 03/2022
1Virus Diseases (Viral Diseases)
11/2022
1Neuroinflammatory Diseases
11/2022
1Nervous System Diseases (Neurological Disorders)
11/2022
1Necrosis
03/2022
1Infections
10/2018

Drug/Important Bio-Agent (IBA)

1Trans-Activators (Trans-Acting Factor)IBA
11/2022
1tat Gene Products (tat Protein)IBA
11/2022
1Ribonucleases (Ribonuclease)IBA
11/2022
17- methyl- 5- (1- ((3- (trifluoromethyl)phenyl)acetyl)- 2,3- dihydro- 1H- indol- 5- yl)- 7H- pyrrolo(2,3- d)pyrimidin- 4- amineIBA
03/2022
1Interleukin-6 (Interleukin 6)IBA
03/2022
1Monocyte Chemoattractant ProteinsIBA
03/2022
1Human Immunodeficiency Virus rev Gene ProductsIBA
10/2018
1Proteins (Proteins, Gene)FDA Link
10/2018

Therapy/Procedure

1Therapeutics
03/2022